Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial
Titel:
Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial
Auteur:
Gershenson, David M Miller, Austin Brady, William E Paul, James Carty, Karen Rodgers, William Millan, David Coleman, Robert L Moore, Kathleen N Banerjee, Susana Connolly, Kate Secord, Angeles Alvarez O'Malley, David M Dorigo, Oliver Gaillard, Stephanie Gabra, Hani Slomovitz, Brian Hanjani, Parviz Farley, John Churchman, Michael Ewing, Ailith Hollis, Robert L Herrington, C Simon Huang, Helen Q Wenzel, Lari Gourley, Charlie
Verschenen in:
Lancet
Paginering:
Jaargang 399 () nr. 10324 pagina's 541-553
Jaar:
2022
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license